RT @GEHealthcare: In the era of precision medicine, breast cancer diagnosis should be no exception. Today, clinicians in the U.S. have access to a new contrast-enhanced breast biopsy tool that can help improve patient experience. @stjosephslondon @lawsonresearch #BCAM #BCAM2020

In the era of precision medicine, breast cancer diagnosis should be no exception. Today, clinicians in the U.S. have access to a new contrast-enhanced breast biopsy tool that can help improve patient experience.
@stjosephslondon @lawsonresearch #BCAM #BCAM2020

— GE Healthcare (@GEHealthcare) October 20, 2020

from Twitter https://twitter.com/GastonR48222321

October 22, 2020 at 02:49PM